News | Computer-Aided Detection Software | January 29, 2018

Lunit Insight Offers Cloud-Based AI Analysis for Chest X-rays

First module in new cloud-based imaging platform improves detection of major chest abnormalities, lung nodule/mass consolidation and pneumothorax

Lunit Insight Offers Cloud-Based AI Analysis for Chest X-rays

January 29, 2018 — Lunit, an artificial intelligence (AI)-powered medical image analysis software company, offered the first live demonstration of Lunit Insight, its new advanced, cloud-based AI solution for real-time image analysis, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago.

The cloud-based imaging platform delivers Lunit’s state-of-the-art AI models; the first one to be unveiled is the chest X-ray solution, which detects major chest abnormalities, lung nodule/mass consolidation, and pneumothorax with 97 percent standalone accuracy in nodule detection, 99 percent for consolidation and pneumothorax. Studies have also shown Lunit Insight to significantly increase the diagnostic performance of its users up to 20 percent, from non-radiology physicians to radiology experts.

Users can upload their medical images online at the Lunit Insight webpage. AI analysis results appear in just a few seconds, including not only the level of abnormality, but also the visualization of the AI’s attention map.

For more information: www.lunit.io

 

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...

Image courtesy of GE Healthcare

Feature | Mobile C-Arms | July 08, 2020 | By Melinda Taschetta-Millane
Moblie C-arms have seen several advances over the past de
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

News | Lung Imaging | July 08, 2020
July 8, 2020 — Changes outlined in new draft U.S.
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane